Comparison of 5‐year outcomes of paclitaxel‐eluting and endeavor zotarolimus‐eluting stents in New York
Sign Up to like & getrecommendations! Published in 2018 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.27000
Abstract: To evaluate long‐term outcomes in patients undergoing either paclitaxel‐eluting stents (PES) or endeavor zotarolimus‐eluting stents (E‐ZES) placement and to assess comparative effectiveness of PES vs. E‐ZES in different “off‐label” and “high‐risk” patient subgroups. read more here.
Keywords: endeavor zotarolimus; zotarolimus eluting; paclitaxel eluting; eluting stents ... See more keywords
Everolimus- versus zotarolimus-eluting stent following percutaneous coronary chronic total occlusion intervention.
Sign Up to like & getrecommendations! Published in 2017 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2017.01.134
Abstract: BACKGROUND Although studies have demonstrated comparable efficacy and safety profiles of everolimus- and zotarolimus-eluting stents (EES and ZES, respectively) for a broad spectrum of coronary artery diseases, there is paucity of data concerning their safety… read more here.
Keywords: intervention; zotarolimus eluting; ees zes; percutaneous coronary ... See more keywords
Long-term comparative effectiveness of Endeavor zotarolimus-eluting and everolimus-eluting stents in New York.
Sign Up to like & getrecommendations! Published in 2017 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2017.03.095
Abstract: BACKGROUND Endeavor zotarolimus-eluting stents (E-ZES) and everolimus-eluting stents (EES) as second-generation stents were approved for use in percutaneous coronary interventions (PCIs) in 2008. We aimed to evaluate the long-term outcomes of E-ZES vs. EES using… read more here.
Keywords: zotarolimus eluting; term; eluting stents; long term ... See more keywords
TCT-92 Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents: 2-Year Clinical Outcomes of the Pooled BIONICS and NIREUS Trials
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2018.08.1188
Abstract: In the BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis (BIONICS) and the NIREUS trials, the safety and efficacy of the novel ridaforolimus-eluting stent (RES) was evaluated, demonstrating the noninferiority of this stent in comparison… read more here.
Keywords: nireus trials; zotarolimus eluting; ridaforolimus; bionics nireus ... See more keywords
TCT-286 Efficacy and Safety of the Newer Generation Zotarolimus-Eluting Stent in Routine Clinical Practice: Data From the IRIS-DES Registry
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2019.08.360
Abstract: The data on efficacy and safety of the newer resolute-Onyx zotarolimus-eluting stents (R-ZES) in routine clinical practice are limited. The authors sought to compare clinical outcomes between the R-ZES and durable polymer everolimus-eluting stent (DP-EES)… read more here.
Keywords: zotarolimus eluting; clinical practice; efficacy safety; eluting stent ... See more keywords
Safety and efficacy of zotarolimus‐eluting stents in the treatment of diabetic coronary lesions in Chinese patients: The RESOLUTE‐DIABETES CHINA Study
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Diabetes"
DOI: 10.1111/1753-0407.12832
Abstract: The RESOLUTE‐DIABETES CHINA study was specifically designed to investigate the safety and efficacy of Resolute zotarolimus‐eluting stents (ZES; Medtronic, Santa Rosa, CA, USA) in the treatment of diabetic coronary lesions in the Chinese population. read more here.
Keywords: zotarolimus eluting; eluting stents; diabetes china; safety efficacy ... See more keywords